ACTSI Investigator Dr. Mark Prausnitz in the News

Mark Prausnitz, PhD, ACTSI investigator, Regents' Professor and Love Family Professor in Chemical & Biomolecular Engineering, School of Chemical Engineering, Georgia Institute of Technology

Study Shows H1N1 Microneedle Vaccine Protects Better Than Injection

Startup Receives $4 Million to Develop Drug Delivery Targeted to the Back of the Eye

Study to Explore Microneedle Patches for Polio Vaccination

Prausnitz was named as the Faculty Communicator of the Year at the Georgia Tech Gold Tower Awards Banquet

Upcoming Events

    View All Events

    Latest News


    ACTSI-supported OculoStaple Wins Again

    Atlanta Clinical & Translational Science Institute (ACTSI)-supported team, OculoStaple wins second place in the 2015 InVenture Prize at Georgia Tech. Team members Jackie Borinski, Mohamad Ali Najia, and Drew Padilla, all biomedical...


    Infographic: What are the Phases of Clinical Trials?